Cefoxitin and ESBL;Céfoxitine et BLSE

Medecine et Maladies Infectieuses

Volumn 42, Issue 3, 2012, Pages 126-128

  Boyer, M ^a   Bignon, A ^a   Dessein, R ^a   Faure, K ^a   Guery, B ^a   Kipnis, E ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cefoxitin; ESBL

Indexed keywords

CEFOXITIN; EXTENDED SPECTRUM BETA LACTAMASE;

ARTICLE;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CATHETER-RELATED INFECTIONS; CEFOXITIN; CROSS INFECTION; DIARRHEA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECALIS; GLYCOPEPTIDES; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; PANCREATIC NEOPLASMS; PNEUMONIA, BACTERIAL; POSTOPERATIVE COMPLICATIONS; PROSTATITIS; SUBSTRATE SPECIFICITY; URINARY CATHETERIZATION;

EID: 84858751878     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2012.01.004     Document Type: Article

References (10)

1. Pitout J. Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae changing epidemiology and drug treatment choices. Drugs 2010, 70(3):313-333.
2. Brumfitt W., Kosmidis J., Hamilton-Miller J., et al. Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology. Antimicrob Agents Chemother 1974, 6(3):290-299.
3. Kass E. Editorial and introduction. Clin Infect Dis 1979, 1(1):1-3.
4. Neu H. Comparative studies of cefoxitin and cephalothin: an overview. Clin Infect Dis 1979, 1(1):144-150.
5. Sanders C., Sanders E. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases. Antimicrob Agents Chemother 1979, 15(6):792-797.
6. Moritz V., Carson P. Cefoxitin sensitivity as a marker for inducible beta-lactamases. J Med Microbiol 1986, 21:203-207.
7. Pangon B., Bizet C., Buré A., et al. In vivo selection of a cephamycin-resistant porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase. J Infect Dis 1989, 159(5):1005-1006.
8. Hoffmann C.E., McDonald P.J., Watts J.M., et al. Use of peroperative cefoxitin to prevent infection after colonic and rectal surgery. Ann Surg 1981, 193(3):353-356.
9. Dworzack D.L., Pugsley M.P., Sanders C., et al. Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins. Eur J Clin Microbiol 1987, 6(4):456-459.
10. Lee C.H., Su L.H., Tang Y.F., et al. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates. J Antimicrob Chemother 2006, 58:1074-1077.